Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress

FASEB Journal

Volumn 27, Issue 11, 2013, Pages 4332-4342

  Tong, Chao ^a   Morrison, Alex ^a   Mattison, Samantha ^a   Qian, Su ^b   Bryniarski, Mark ^a   Rankin, Bethany ^a   Wang, Jun ^c   Thomas, D Paul ^d   Li, Ji ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c TEXAS HEART INSTITUTE   (United States)

^d UNIVERSITY OF WYOMING   (United States)

Author keywords

Myocardial infarction; Sirtuin 1; Sumoylation

Indexed keywords

CARDIOVASCULAR AGENT; SIRTUIN 1; SRT 1720; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; GENE OVEREXPRESSION; GENE TRANSLOCATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART STRESS; IMMUNOBLOTTING; KNOCKOUT GENE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SENESCENCE; SUMOYLATION;

MYOCARDIAL INFARCTION; SIRTUIN 1; SUMOYLATION;

ACTIVE TRANSPORT, CELL NUCLEUS; AGE FACTORS; AGING; ANIMALS; CELL NUCLEUS; CYSTEINE ENDOPEPTIDASES; CYTOPLASM; HEART; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PROTEIN TRANSPORT; SIRTUIN 1; STRESS, PHYSIOLOGICAL; SUMOYLATION;

EID: 84885615564     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-216473     Document Type: Article

References (48)

1. Cohen, H. Y, Miller, C, Bitterman, K.J., Wall, N. R, Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R, and Sinclair, D. A. (2004) Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305, 390-392 (Pubitemid 38938153)
2. Kaeberlein, M., McVey, M., and Guarente, L. (1999) The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13, 2570-2580 (Pubitemid 29489648)
3. Tissenbaum, H. A., and Guarente, L. (2001) Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410, 227-230 (Pubitemid 32216597)
4. Rogina, B., and Helfand, S. L. (2004) Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. U. S. A. 101, 15998-16003 (Pubitemid 39507916)
5. Wang, R. H., Sengupta, K, Li, C, and Kim., H. S., Cao, L., Xiao, C, Kim, S., Xu, X., Zheng, Y., Chilton, B., Jia, R., Zheng, Z. M., Appella, E., Wang, X. W., Ried, T., and Deng, C. X. (2008) Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 14, 312-323
6. Boily, G., and He., X. H., Pearce, B., Jardine, K, and McBurney, M. W. (2009) SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol. Oncogene 28, 2882-2893
7. Ota, H., Tokunaga, E., Chang, K, Hikasa, M., Iijima, K, Eto, M., Kozaki, K, Akishita, M., Ouchi, Y, and Kaneki, M. (2006) Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene 25, 176-185 (Pubitemid 43083679)
8. Cheng, H. L., Mostoslavsky, R., Saito, S., Manis, J. P., Gu, Y., Patel, P., Bronson, R., Appella, E., and Alt., F. W., and Chua, K F. (2003) Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 100, 10794-10799 (Pubitemid 37140107)
9. Shindler, K. S., Ventura, E., Rex, T. S., Elliott, P., and Rostami, A. (2007) SIRT1 activation confers neuroprotection in experimental optic neuritis. Invest. Ophthalmol. Vis. Sci. 48, 3602-3609 (Pubitemid 351261095)
10. Tanno, M., Sakamoto, J., Miura, T., Shimamoto, K, and Horio, Y. (2007) Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J. Biol. Chem. 282, 6823-6832 (Pubitemid 47100909)
11. Yang, Y, Fu, W., Chen, J., Olashaw, N., Zhang, X., Nicosia, S. V., Bhalla, K, and Bai, W. (2007) SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Nat. Cell Biol. 9, 1253-1262 (Pubitemid 350042357)
12. Fulco, M., Cen, Y, Zhao, P., and Hoffman., E. P., McBurney, M. W., Sauve, A A, and Sartorelli, V. (2008) Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev. Cell. 14, 661-673 (Pubitemid 351622608)
13. Alcendor, R R, Kirshenbaum, L. A., Imai, S., Vatner, S. F., and Sadoshima, J. (2004) Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ. Res. 95, 971-980 (Pubitemid 39532327)
14. Alcendor, R. R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., Tian, B., Wagner, T., Vatner, S. F., and Sadoshima, J. (2007) Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 100, 1512-1521 (Pubitemid 46834764)
15. Mathers, C, Fat, D. M., and Boerma, J. T., eds. (2008) The global burden of disease: 2004 update. World Health Organization, Geneva, Switzerland/Ebrary, Inc., Palo Alto, CA, USA
16. Azhar, G., Gao, W., Liu, L. X., and Wei, J. Y. (1999) Ischemiareperfusion in the adult mouse heart influence of age. Exp. Gerontol. 34, 699-714 (Pubitemid 29420332)
17. Xu, F., Gao, Z., Zhang, J., Rivera, C. A., Yin, J., Weng, J., and Ye, J. (2010) Lack of SIRT1 (mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: a role of lipid mobilization and inflammation. Endocrinology 151, 2504-2514
18. Wang, J., and Schwartz, R.J. (2010) Sumoylation and regulation of cardiac gene expression. Circ. Res. 107, 19-29
19. Miller, E. J., Li, J., Leng, L., McDonald, C, Atsumi, T., Bucala, R, and Young, L. H. (2008) Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature 4 51, 578-582 (Pubitemid 351186266)
20. Wang, J., Yang, L., Rezaie, A. R., and Li, J. (2011) Activated protein C protects against myocardial ischemic/reperfusion injury through AMP-activated protein kinase signaling. J. Thromb. Haemost. 9, 1308-1317
21. Morrison, A., Yan, X., Tong, C., and Li, J. (2011) Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice. Am. J. Physiol. Heart Circ. Physiol. 301, H895-H902
22. Ma, H., Wang, J., Thomas, D. P., Tong, C, Leng, L., Wang, W., Merk, M., Zierow, S., Bernhagen, J., Ren, J., Bucala, R., and Li, J. (2010) Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart. Circulation 122, 282-292
23. Lin, J. F., and Lin., S. M., Chih, C. L., Nien, M. W., and Su., H. H., Hu, B. R., Huang, S. S., and Tsai, S. K (2008) Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats. Life Sci. 83, 313-317
24. Russell, R. R., 3rd, Li, J., Coven, D. L., Pypaert, M., Zechner, C, Palmeri, M., Giordano, F. J., Mu, J., Birnbaum, M. J., and Young, L. H. (2004) AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J. Clin. Invest. 114, 495-503 (Pubitemid 39572099)
25. Wang, J., Ma, H., Tong, C, Zhang, H., and Lawlis., G. B., Li, Y., Zang, M., Ren, J., and Nijland., M. J., Ford, S. P., Nathanielsz, P. W., and Li, J. (2010) Overnutrition and maternal obesity in sheep pregnancy alter the JNK-IRS-1 signaling cascades and cardiac function in the fetal heart. FASEBJ. 24, 2066-2076
26. Tong, C., Morrison, A., Yan, X., Zhao, P., and Yeung., E. D., Wang, J., Xie, J., and Li, J. (2010) Macrophage migration inhibitory factor deficiency augments cardiac dysfunction in type 1 diabetic murine cardiomyocytes. J. Diabetes. 2, 267-274
27. Yeung, E. D., Morrison, A., Plumeri, D., Wang, J., Tong, C., Yan, X., and Li, J. (2012) Alternol exerts prostate-selective antitumor effects through modulations of the AMPK signaling pathway. Prostate 72, 165-172
28. Shi, X., Leng, L., Wang, T., Wang, W., Du, X., Li, J., McDonald, C., Chen, Z., Murphy, J. W., Lolis, E., Noble, P., Knudson, W., and Bucala, R. (2006) CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25, 595-606 (Pubitemid 44529040)
29. Hay, R. T. (2005) SUMO: a history of modification. Mol Cell 18, 1-12 (Pubitemid 40444643)
30. Bayer, P., Arndt, A., Metzger, S., Mahajan, R., Melchior, F., Jaenicke, R., and Becker, J. (1998) Structure determination of the small ubiquitin-related modifier SUMO-1. J. Mol. Biol. 280, 275-286 (Pubitemid 28325519)
31. Kim, E. Y, Chen, L., Ma, Y, Yu, W., Chang, J., Moskowitz, I. P., and Wang, J. (2012) Enhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction. J. Mol. Cell. Cardiol. 52, 638-649
32. Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., and Spiegelman., B. M., and Puigserver, P. (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434, 113-118 (Pubitemid 40349395)
33. Canto, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., and Elliott., P. J., Puigserver, P., and Auwerx, J. (2009) AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056-1060
34. Milne, J. C., and Lambert., P. D., Schenk, S., Carney, D. P., and Smith., J. J., Gagne, D.J., Jin, L., Boss, O., Perni, R. B., and Vu., C. B., Bemis, J. E., Xie, R., Disch, J. S., Ng, P. Y, Nunes, J. J., Lynch, A. V., Yang, H., Galonek, H., Israelian, K, Choy, W., Iffland, A., Lavu, S., Medvedik, O., Sinclair, D. A., Olefsky, J. M., Jirousek, M. R., Elliott, P. J., and Westphal, C. H. (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450, 712-716 (Pubitemid 350207685)
35. Claycomb, W. C., and Lanson., N. A., Jr., Stallworth, B. S., Egeland, D. B., Delcarpio, J. B., Bahinski, A., and Izzo, N. J., Jr. (1998) HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. U. S. A. 95, 2979-2984 (Pubitemid 28135840)
36. Xie, Z. L., Koyama, T., Abe, K, Fujii, Y., Sawa, H., and Nagashima, K (2000) Upregulation of p53 protein in rat heart subjected to a transient occlusion of the coronary artery followed by reperfusion. Jpn. J. Physiol. 50, 159-162 (Pubitemid 30243420)
37. Vaziri, H., Dessain, S. K, Eagon, E. N., and Imai., S. I., Frye, R. A., Pandita, T. K, Guarente, L., and Weinberg, R. A. (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107, 149-159 (Pubitemid 33035942)
38. Fukuda, I., Ito, A., Hirai, G., Nishimura, S., Kawasaki, H., Saitoh, H., Kimura, K, Sodeoka, M., and Yoshida, M. (2009) Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate. Chem. Biol. 16, 133-140
39. Stade, K, Vogel, F., Schwienhorst, I., Meusser, B., Volkwein, C., Nentwig, B., Dohmen, R. J., and Sommer, T. (2002) A lack of SUMO conjugation affects cNLS-dependent nuclear protein import in yeast. J. Biol. Chem. 277, 49554-49561 (Pubitemid 36014394)
40. Cai, Q., and Robertson, E. S. (2010) Ubiquitin/SUMO modification regulates VHL protein stability and nucleocytoplasmic localization. PLoS One 5, e12636
41. Wei, F., and Scholer., H. R., and Atchison, M. L. (2007) Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. J. Biol. Chem. 282, 21551-21560 (Pubitemid 47099909)
42. Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X. B., Soron, G., Cooper, B., Brayton, C., Park, S. H., Thompson, T., Karsenty, G., Bradley, A., and Donehower, L. A. (2002) p53 mutant mice that display early ageing-associated phenotypes. Nature 415, 45-53 (Pubitemid 34062443)
43. Li, F., Zhang, L., Craddock, J., Bruce-Keller, A. J., Dasuri, K, Nguyen, A., and Keller, J. N. (2008) Aging and dietary restriction effects on ubiquitination, sumoylation, and the proteasome in the heart. Mech. Ageing Dev. 129, 515-521
44. Hsu, C. P., Zhai, P., Yamamoto, T., Maejima, Y, Matsushima, S., Hariharan, N., Shao, D., Takagi, H., Oka, S., and Sadoshima, J. (2010) Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 122, 2170-2182
45. Yang, T. L., and Sauve, A. A. (2006) NAD metabolism and sirtuins: Metabolic regulation of protein deacetylation in stress and toxicity. AAPS J. 8, E632-E643 (Pubitemid 44644162)
46. Dasgupta, B., and Milbrandt, J. (2007) Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl. Acad. Sci. U. S. A. 104, 7217-7222 (Pubitemid 47186035)
47. Zhang, H., Saitoh, H., and Matunis, M.J. (2002) Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol. Cell. Biol. 22, 6498-6508
48. Smith, J. J., and Kenney., R. D., Gagne, D. J., Frushour, B. P., Ladd, W., and Galonek., H. L., Israelian, K, Song, J., Razvadauskaite, G., Lynch, A. V., Carney, D. P., Johnson, R. J., Lavu, S., Iffland, A., Elliott, P. J., Lambert, P. D., Elliston, K. O., Jirousek, M. R., Milne, J. C., and Boss, O. (2009) Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo. BMC Syst. Biol. 3, 31